Changhai Hospital Affiliated to the Second Military Medical University, Shanghai, China
Copyright 2016, American College of Chest Physicians. All Rights Reserved.
SESSION TITLE: Cardiothoracic
SESSION TYPE: Original Investigation Poster
PRESENTED ON: Saturday, April 16, 2016 at 11:45 AM - 12:45 PM
PURPOSE: To set up a simple and practical classification system for identifying pulmonary tuberculosis (PTB) patients who will benefit most from adjunctive surgical therapy.
METHODS: We set up a classification system (LTB-S), based on lesions(L), time of treatment(T), body condition(B) and symptom/sign(S) of candidates. In this observational study, 35 PTB patients, including multi drug-resistant tuberculosis (MDR-TB) and extensively drug resistant tuberculosis (XDR-TB), voluntarily underwent analysis and classification into three types: Type I (absolute surgical indication), Type II (relative indication) and Type III (contraindication). The occurrence of postoperative complication was used to assess the value of the classification.
RESULTS: Among 35 patients, there were 12 Type I, 23 Type II and 2 Type III patients according to the LTB-S classification. Postoperative complications included bronchopleural fistula in 2 patients, contralateral pulmonary dissemination of tuberculosis in 2 patients and massive bleeding in 1 patient. Operation-related complications were not seen in Type I patients, but occurred in both (100%) of the Type III patients. Patients were followed up for between 10 and 120 months after surgery. There was no relapse except for both patients of Type III.
CONCLUSIONS: The study showed the potential value of the LTB-S classification system, which is an objective judgment strategy for surgical treatment of TB. Additional prospective studies with more patients are needed to further validate this system.
CLINICAL IMPLICATIONS: The LTB-S classification system is helpful to objectively select those pulmonary tuberculosis patients who may benefit most from adjunctive surgical treatment.
DISCLOSURE: The following authors have nothing to disclose: Fan Xia, Chen Hui, Pei Wang, YiJun Zhu, Heping Xiao, Shuihua Lu, Lowrie Douglas B., Wang Xu, Dai Xiyong, Yanzheng Song, Qiang Li
No Product/Research Disclosure Information
Become a CHEST member and receive a FREE subscription as a benefit of membership.
Individuals can purchase this article on ScienceDirect.
Individuals can purchase a subscription to the journal.
Individuals can purchase a subscription to the journal or buy individual articles.
Learn more about membership or Purchase a Full Subscription.
Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.
Some tools below are only available to our subscribers or users with an online account.
Download citation file:
Web of Science® Times Cited:
Customize your page view by dragging & repositioning the boxes below.
Enter your username and email address. We'll send you a reminder to the email address on record.
Athens and Shibboleth are access management services that provide single sign-on to protected resources. They replace the multiple user names and passwords necessary to access subscription-based content with a single user name and password that can be entered once per session. It operates independently of a user's location or IP address. If your institution uses Athens or Shibboleth authentication, please contact your site administrator to receive your user name and password.